Mechanistic Insights into the Action of PSO CARE on Psoriatic Pathophysiology. This diagram illustrates how regular topical application of PSO CARE targets multiple inflammatory pathways in psoriasis. Topical PSO CARE modulates Th1 and Th17 pathways by inhibiting NF-κB activation and reducing pro-inflammatory cytokines (TNF-α, IL-6, IL-17, IL-23).
Mechanistic action of PSO CARE on psoriatic inflammation
UNDERSTANDING
THE MECHANISM
Key components, including bakuchiol and ar-turmerone, also enhance antioxidant defences, mitigating oxidative stress from ROS/RNS in psoriatic skin. Collectively, these effects reduce inflammation and alleviate psoriatic symptoms.
WHAT THIS MEANS TO YOU
PSO CARE works to reduce psoriasis symptoms by targeting key inflammatory pathways in your skin.
It inhibits overactive immune responses (Th1 and Th17 pathways) and reduces harmful inflammatory substances like TNF-α, IL-6, IL-17, and IL-23, which are known to worsen psoriasis.
The natural ingredients in PSO CARE, such as bakuchiol and ar-turmerone, also strengthen your skin’s antioxidant defenses, protecting it from further damage caused by oxidative stress.
For you, this means relief from redness, itching, and scaling, with healthier, more resilient skin over time.